Novel mutations of ITGB2 induced leukocyte adhesion defect type 1

Objective: To investigate the pathogenic mechanism of two novel ITGB2 mutations in leukocyte adhesion defect type 1 (LAD1). Methods: The clinical history and blood sample of an 11 years old patient admitted to Affiliated Hospital of Qingdao University in August 2014 were collected. Expression of CD1...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 56(2018), 8 vom: 02. Aug., Seite 617-622
1. Verfasser: Lin, Y (VerfasserIn)
Weitere Verfasser: Zheng, H Y, Xian, Y Y, Chang, H, Lei, K, Wang, B T, Zhang, Q Y
Format: Online-Aufsatz
Sprache:Chinese
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:Case Reports Journal Article Antigens, CD18 Cell adhesion molecules Genes Immunologic deficiency syndromes CD18 Antigens ITGB3 protein, human Integrin beta3
LEADER 01000naa a22002652 4500
001 NLM287177769
003 DE-627
005 20231225053433.0
007 cr uuu---uuuuu
008 231225s2018 xx |||||o 00| ||chi c
024 7 |a 10.3760/cma.j.issn.0578-1310.2018.08.012  |2 doi 
028 5 2 |a pubmed24n0957.xml 
035 |a (DE-627)NLM287177769 
035 |a (NLM)30078245 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Lin, Y  |e verfasserin  |4 aut 
245 1 0 |a Novel mutations of ITGB2 induced leukocyte adhesion defect type 1 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 01.04.2019 
500 |a Date Revised 01.04.2019 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Objective: To investigate the pathogenic mechanism of two novel ITGB2 mutations in leukocyte adhesion defect type 1 (LAD1). Methods: The clinical history and blood sample of an 11 years old patient admitted to Affiliated Hospital of Qingdao University in August 2014 were collected. Expression of CD18 (encoded by ITGB2) was analyzed by flow cytometry. Novel ITGB2 mutations were identified by next-generation sequencing technology and confirmed by Sanger sequencing. The functional effect of ITGB2 mutations was detected by PolyPhen2. Expression vectors of both wild type and mutant ITGB2 were constructed and transfected into mammalian cells for analysis of protein stability and subcellular location. Results: The symptoms of the patient (recurrent infections, lowered alveolar ridge and hypodontia) supported the diagnosis of LAD1. Expression of CD18 on the leukocytes was significantly decreased (0.2%) compared with the control samples from the parents (paternal: 99.0%; maternal: 99.1%). The patient was identified to be compound heterozygous for ITBG2 c.954del G (novel mutation) and c.1802C>A (paternal originated). ITGB2 c.954 del G was confirmed to be a harmful frameshift mutation; ITGB2 c.1802C>A was also predicted to be harmful. In terms of protein stability. There was no significant difference between mutant D18 and wild type. However, subcellular location analysis showed the mutant D18 could not locate on cell membrane. Conclusion: The compound heterozygous of ITGB2 mutations (c.954del G and c.1802C>A) decreases the expression and impairs the location of CD18 on leukocytes, which leads to LAD1 
650 4 |a Case Reports 
650 4 |a Journal Article 
650 4 |a Antigens, CD18 
650 4 |a Cell adhesion molecules 
650 4 |a Genes 
650 4 |a Immunologic deficiency syndromes 
650 7 |a CD18 Antigens  |2 NLM 
650 7 |a ITGB3 protein, human  |2 NLM 
650 7 |a Integrin beta3  |2 NLM 
700 1 |a Zheng, H Y  |e verfasserin  |4 aut 
700 1 |a Xian, Y Y  |e verfasserin  |4 aut 
700 1 |a Chang, H  |e verfasserin  |4 aut 
700 1 |a Lei, K  |e verfasserin  |4 aut 
700 1 |a Wang, B T  |e verfasserin  |4 aut 
700 1 |a Zhang, Q Y  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 56(2018), 8 vom: 02. Aug., Seite 617-622  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnns 
773 1 8 |g volume:56  |g year:2018  |g number:8  |g day:02  |g month:08  |g pages:617-622 
856 4 0 |u http://dx.doi.org/10.3760/cma.j.issn.0578-1310.2018.08.012  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 56  |j 2018  |e 8  |b 02  |c 08  |h 617-622